• The global service robotics market is projected to exceed $107 billion by 2030 as commercialization replaces experimentation
• TechForce Robotics delivers both TIM-E mobility robots and BIM-E beverage automation through a fully managed Robotics-as-a-Service Provider subscription model
• Modular transport systems and automated beverage platforms are designed for high-traffic, real-world hospitality and institutional environments

Autonomous-driven robotics is shifting from concept demonstrations to measurable operational deployment. As labor shortages and wage pressures persist across hospitality, healthcare and public venues, automation is increasingly viewed as infrastructure rather than innovation theater.

Nightfood Holdings Inc. (d.b.a. TechForce Robotics) (OTCQB: NGTF), is aligning with that transition by deploying both autonomous mobility platforms and automated beverage systems built for live, revenue-generating environments.

Commercialization Replaces Concept Robotics

Industry forecasts from multiple market research firms project the global service robotics market could surpass $107 billion by 2030, driven by adoption in hospitality, logistics, healthcare and entertainment. The primary driver is not technological curiosity but operational necessity. Facilities need systems that reduce repetitive labor and fill in gaps, all while maintaining consistency, throughput and safety.

Within this shift, the distinction between pilot programs and scalable deployment is becoming clearer. Robots must operate reliably in crowded spaces, integrate with existing workflows and demonstrate clear economic value.

TechForce Robotics has structured its approach around that deployment-first philosophy.

TIM-E: A Scalable Platform for Physical Movement

TIM-E (pronounced “Timmy”) is TechForce’s modular autonomous service robot designed to move items efficiently across large, complex facilities. Delivered through a Robotics-as-a-Service Provider subscription structure, TIM-E integrates hardware, navigation software, deployment mapping, support and ongoing optimization into a single managed solution.

Rather than deploying separate machines for each task, TIM-E supports modular attachments that allow one platform to handle luggage transport, linen movement, waste collection, housekeeping supply runs, concession support and secure locked-cart workflows. This flexibility enables facilities to adjust automation as operational demands evolve without replacing core infrastructure.

The system is engineered for active environments. According to TechForce materials, robots use LiDAR-based SLAM navigation, depth sensing, RGB cameras and layered sensor systems to operate safely around guests and staff. Precision mapping and dynamic routing allow units to adjust when hallways become congested, while elevator integration enables multi-floor operation.

The focus is not experimental autonomy but consistent back-of-house execution in real facilities.

BIM-E: Automated Beverage Service at Scale

Complementing mobility automation, TechForce also deploys BIM-E, an automated beverage dispensing system designed for high-traffic service environments. Like TIM-E, BIM-E is delivered through the company’s subscription-based Robotics-as-a-Service Provider framework, delivering consistent pours of beer, wine, coffee, kombucha, seltzer, and other beverages.

BIM-E is built to automate beverage pours with consistency and speed, maintaining throughput during peak demand in hotels, casinos, convention centers and restaurants. The system emphasizes repeatable precision to reduce waste and variability, while freeing staff to focus on guest interaction rather than repetitive pouring tasks.

The company notes that one bartender can manage multiple BIM-E units simultaneously, reflecting the broader industry push toward workforce-supportive automation rather than workforce replacement. POS integration and compatibility with various beverage types including beer, wine, coffee and specialty drinks allow the system to adapt across service environments.

By pairing physical mobility automation with beverage service automation, TechForce is building an ecosystem approach rather than a single-product strategy.

Robotics-as-a-Service Redefines Adoption

A central feature of TechForce’s commercialization strategy is its Robotics-as-a-Service Provider model. Instead of requiring capital purchases and long procurement cycles, automation is delivered as an operating expense subscription that includes deployment, mapping, maintenance, software updates and 24/7 monitoring.

Facilities can scale fleets up or down, modify attachments and adjust workflows as operational conditions change. This flexibility mirrors the broader evolution of enterprise technology adoption, where subscription infrastructure replaced capital-intensive ownership.

The RaaSP framework lowers financial barriers while aligning recurring revenue with ongoing service and optimization.

From Tools to Infrastructure

The broader robotics industry appears to be entering a stage where commercialization metrics matter more than prototype novelty. Real-world reliability, subscription economics and integration into daily workflows are becoming defining characteristics of market leaders.

By combining TIM-E’s modular mobility platform with BIM-E’s automated beverage service, both delivered through a managed subscription model, TechForce Robotics is positioning its portfolio within that infrastructure phase of service automation.

As industries continue to prioritize operational consistency, labor efficiency and scalable deployment, the movement from experimentation to execution may define the next chapter of service robotics adoption.

For more information, visit the company’s website at TechForceRobotics.com.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

• ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties, just announced the appointment of Jason Tong as its new CFO
• Mr. Tong will lend his experience spanning more than 15 years, equipping ESGold with the support needed for its next phase of growth
• Tong will be key in driving the company’s financial strategy as it transitions toward becoming a producing gold and silver company
  

ESGold (CSE: ESAU) (OTCQB: ESAUF), a development-stage company committed to acquiring, exploring, and developing high-quality mineral properties worldwide, just announced the appointment of Mr. Jason Tong, CPA, CA, CFA, as the company’s Chief Financial Officer (“CFO”), effective immediately. Mr. Tong takes over from Mr. Tony Giuliano, and will play an integral role as the company transitions from development to production at its flagship Montauban Gold-Silver project (https://ibn.fm/0HcCq).

“Jason joins ESGold at a pivotal stage in the company’s evolution,” noted Gordon Robb, ESGold’s CEO. “Jason’s experience working with publicly listed companies and his deep understanding of capital markets, financial reporting, and corporate governance make him an excellent addition to our leadership team as we continue building ESGold into a producing mining company,” he added (https://ibn.fm/IGMmL).

Mr. Tong brings 15 years of experience, previously serving as CFO for Pathway Capital Ltd., a venture capital firm that manages a portfolio of early-stage companies with market capitalizations ranging from $5 million to $100 million. He also has experience working with publicly listed companies across the Nasdaq, TSX, and TSXV exchanges, serving in senior financial leadership and advisory roles in the mining, venture capital, and finance sectors.

With Mr. Tong’s addition, the company is set to realize their Montauban property’s full potential as it moves to production and further exploration. “We are assembling the operational and financial framework required to support ESGold’s next phase of growth, including production, expansion, or exploration activities, and continued engagement with the capital markets. Jason’s appointment represents another important step in that process,” Mr. Robb noted (https://ibn.fm/IGMmL).

This appointment follows the recent closing of its brokered LIFE offering, which raised gross proceeds of C$7.2 million. The offering involved the sale of 10,683,000 units of the company at C$0.68 per share, with proceeds to be used to advance the Montauban project and for general working capital and corporate purposes (https://ibn.fm/VMNYy). Mr. Tong’s oversight will ensure accountability for these proceeds, enabling the company to achieve both its short- and long-term objectives with the Montauban property.

“I am pleased to be joining ESGold at such an exciting time in the company’s development. With a fully permitted project, a clear path toward production, and expanding exploration potential at Montauban, ESGold is entering an important stage of growth,” noted Mr. Tong. “I look forward to working with the management team and Board to support the company’s financial strategy as it transitions toward becoming a producing gold and silver company,” he added (https://ibn.fm/IGMmL).

For company information, visit the company’s website at www.ESGold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• Safe Pro recently announced that it has completed the company’s participation in a recent U.S. Army event where soldiers used Safe Pro’s AI tools in real-world operational environments.
• Safe Pro’s patented Safe Pro Object Threat Detection (“SPOTD”) drone imagery analysis platform was used by soldiers to identify ground-based threats during day and night exercises.
• The threat data collected was also used by the company’s edge-based Navigation, Observation & Detection Engine (“NODE”) to create 2D/3D terrain maps and digital surface models to inform route and mission planning.

Safe Pro Group (NASDAQ: SPAI), a developer of AI-powered defense, security, and situational awareness solutions, recently announced that the company has completed its participation in the U.S. Army Transforming in Contact (“TiC”) 2.0 Autonomous Breach (https://ibn.fm/Tndrj) event.

At the event, Safe Pro’s patented AI tools were successfully used in real-world operational environments by command personnel and soldiers throughout the two-week-long exercise that took place at Ford Hood in Texas.

The U.S. Army wants to put $1 billion into TiC 2.0 to sponsor and fund the equipping and testing of advanced technology like drones mission planning technologies, directly with soldiers. During the recent invite only event, participating teams were given a chance to demonstrate and integrate their technologies with a group of soldiers.

For Safe Pro, the company’s Safe Pro Object Threat Detection (“SPOTD”) AI-powered drone imagery analysis platform was used by soldiers operating and training in the field. During the exercises, soldiers relied on the company’s AI tools day and night to quickly identify ground-based threats in drone images, including mines, barbed wire, obstacles, and fortifications.

This AI platform is capable of detecting and identifying more than 150 types of landmines and unexploded ordnance (“UXO”) and has been deployed in Ukraine for nearly three years, and is supported by a dataset that features over 2.4 million analyzed images. The technology also has identified over 45,600 threats, and covered around 29,900 acres of land.

In addition to simply identifying these threats, threat detections and related location data were integrated into situational awareness and mission planning tools including soldier-carried devices running the Tactical Awareness Kit (“TAK”) and General Dynamics Mission Systems’ GeoSuite. Also, the threat and obstacle data was also processed by Safe Pro’s edge-based Navigation, Observation & Detection Engine (“NODE”) to create 2D/3D terrain maps and digital surface models used by command personnel to inform both mission and route planning.

Speaking about the company’s participation in the event, Safe Pro Chairman and CEO, Dan Erdberg, said “We are thankful for the opportunity to participate in the Army’s TiC 2.0 and were thrilled to see how quickly our AI tools were successfully utilized by soldiers to provide actionable intelligence and battlefield situational awareness.”

He also added that “Our performance at TiC 2.0 has resulted in a significant expansion of our pipeline, driving multiple new capability requests from the Army personnel in attendance. Our teams are working diligently to support these requests as momentum continues to build for our technology within the Army.”

About Safe Pro Group Inc. (NASDAQ: SPAI)

Safe Pro Group Inc. is a mission-driven tech company that delivers advanced AI-powered security and defense solutions to customers in the defense, homeland security, humanitarian, and law enforcement industries. At the core of Safe Pro’s mission is the company’s computer vision software technology that’s used to rapidly detect small objects in drone footage.

For more information, visit the company’s website at www.SafeProGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SPAI are available in the company’s newsroom at  https://ibn.fm/SPAI

• The company has introduced a Self-Service Mortgage Experience (“SSME”) allowing borrowers to review loan customized scenarios and lock rates online without speaking to a loan officer.
• The feature provides a 24/7 digital mortgage pathway, reflecting growing demand for self-directed financial services among Millennials and Gen Z.
• Beeline’s AI-powered platform processes applications in seconds and presents personalized mortgage rate options rather than static rate quotes.
• The company’s broader digital infrastructure enables loan closings in 14–21 days, significantly faster than the traditional mortgage timeline.
• The platform targets two major demographic opportunities: younger homebuyers an investors seeking entry into property markets, plus older homeowners accessing home equity.

Beeline Holdings (NASDAQ: BLNE),  a fast-growing digital mortgage platform redefining the path to homeownership, announced the launch of a new automated lending pathway designed to streamline the home financing process. The company recently introduced its Self-Service Mortgage Experience (“SSME”), a platform feature that allows borrowers to explore customized loan options, model mortgage scenarios and lock interest rates entirely online. According to a company announcement, the first phase of the feature launched on March 11 and is currently available to roughly half of conventional mortgage applicants using Beeline’s platform (https://ibn.fm/ekxEb).

The feature reflects a broader shift across financial services as consumers increasingly expect digital-first experiences similar to those offered by technology platforms. In the mortgage sector, where loan approvals and document processing have historically involved multiple intermediaries and extended timelines, companies are investing heavily in automation to reduce friction.

Beeline’s platform allows borrowers to complete several steps of the mortgage process independently. After submitting an application through the company’s digital portal, the system processes borrower data and produces customized loan rate options within seconds. Borrowers can then explore scenarios and request a rate lock at any time. The system operates continuously, giving customers the option to progress through early stages of the mortgage process without waiting for business hours or scheduling a call with a loan officer. A digital assistant known as “Bob” is embedded in the platform to answer questions during the process. Borrowers can still connect with Beeline loan specialists if they prefer human guidance.

Jess Kennedy, chief operating officer of Beeline Financial Holdings, Beeline’s principal operating subsidiary, said the platform was designed to give borrowers greater transparency earlier in the lending process. “Customers can review potential loan scenarios and request a rate lock when they’re ready—on their own timetable—while still having the ability to connect with a Loan Guide whenever they want support,” Kennedy said.

The rollout is the first stage of a broader development roadmap intended to digitize additional parts of the mortgage process. Borrowers on the platform already complete steps such as signing disclosures, uploading documentation and paying for appraisals online. Future iterations are expected to allow borrowers to complete even more of the mortgage workflow independently.

The initiative comes as demographic shifts reshape the housing market. Millennials and members of Generation Z have become a growing share of mortgage applicants, yet homeownership rates for those cohorts remain below earlier generations. According to analysis cited by the company, about 26.1% of Gen Z adults and roughly 54.9% of Millennials owned homes in 2024, a modest increase from the previous year. Limited access to mortgages has been cited as a key barrier for younger buyers, according to reporting from National Mortgage Professional (https://ibn.fm/d0OKI). Beeline is positioning its digital mortgage tools partly as a response to that challenge.

The company says its AI-based underwriting engine can provide applicants with a preliminary qualification decision in approximately seven to eight minutes, offering borrowers a clearer understanding of their financing prospects early in the process. That capability is expected to appeal particularly to gig-economy workers and self-employed borrowers, whose income patterns often complicate traditional mortgage underwriting. Beyond first-time homebuyers, the platform is also targeting younger investors interested in acquiring rental properties. Beeline reports that a meaningful share of its loan originations support buyers purchasing investment real estate.

By lowering friction in the mortgage process, the company aims to make property investment more accessible to younger borrowers who may otherwise face barriers when navigating conventional lending systems. At the same time, the platform is designed to address a separate demographic opportunity among older homeowners. Many baby boomers hold substantial equity in their homes after decades of price appreciation.

Industry estimates suggest U.S. homeowners collectively hold roughly $10 trillion in home equity, creating demand for financial products that allow older borrowers to access that capital without selling their properties. Beeline has developed a range of lending and home-equity products to serve that segment.

The company operates through its primary lending subsidiary, Beeline Loans Inc., and also runs Beeline Title, an integrated closing and settlement services provider. Together, these operations form what the company describes as an end-to-end digital mortgage ecosystem.

Automation plays a central role in that system. Beeline’s proprietary production engine, known as Hive, manages much of the loan workflow, enabling the company to complete mortgage closings in approximately 14 to 21 days. That timeframe is significantly shorter than the traditional industry average, which can exceed a month. By expanding the number of mortgage steps borrowers can complete independently, the company is attempting to reduce costs, shorten timelines and provide customers with more control over the financing process.

For more information, visit the company’s website at www.MakeABeeline.com.

NOTE TO INVESTORS: The latest news and updates relating to BLNE are available in the company’s newsroom at https://ibn.fm/BLNE

The relationship between growth companies and the capital markets has rarely been static. Periods of economic expansion often reward bold innovation and aggressive scaling, while more disciplined market environments place greater emphasis on operational execution, capital efficiency, and strategic clarity. As markets continue to recalibrate following several years of volatility and shifting interest-rate expectations, the dialogue between investors and emerging growth companies has become increasingly focused on fundamentals.

That evolving conversation will be front and center at the 38th Annual ROTH Conference, taking place March 22–24, 2026, in Dana Point, California. The event is expected to bring together approximately 500 public and private companies across a broad range of sectors, including consumer, technology and media, sustainability, industrial growth, AgTech, energy, metals and mining, healthcare, services, and insurance.

Industry gatherings have long played an important role in the growth-company ecosystem, but their function has evolved alongside the market itself. Investors today are increasingly focused on identifying companies capable of translating innovation into durable operating performance. For management teams, that means demonstrating not only the strength of their market opportunity, but also the discipline behind their capital allocation and long-term strategy.

The structure of the Roth Conference reflects this dynamic. In addition to company presentations, the program features industry panels, analyst-led fireside chats, and structured one-on-one and small-group meetings between investors and corporate leadership. These formats allow participants to move beyond headline narratives and engage in deeper conversations about strategy, sector trends, and the broader forces shaping the growth-company landscape.

Another defining characteristic of the event is the diversity of industries represented. Bringing together companies from multiple sectors creates opportunities for investors to identify emerging themes and cross-industry trends that may not be visible within a single vertical. For executives, it provides valuable perspective on how capital is flowing across different parts of the innovation economy.

Equally important are the connections formed through direct interaction. One-on-one meetings between investors and management teams remain one of the most effective ways to build long-term capital relationships, particularly in the small- and mid-cap universe where understanding leadership and strategy can be just as important as analyzing financial performance.

As the growth-company landscape continues to evolve, events like the Roth Conference serve as an important forum for these conversations. By bringing together investors, corporate leaders, and industry experts in a single setting, the conference provides a platform where new ideas are exchanged, relationships are formed, and the next generation of market leaders begins to take shape.

For companies navigating today’s capital markets, and for investors seeking the next wave of innovation, the discussions taking place in Dana Point this March are likely to offer valuable insight into where the growth economy is headed next. For more information on the conference, visit www.Roth.com/38thAnnualConference.

• Designations granted by leading global regulatory agencies play a critical role in advancing drug-development programs.
• The UK Medicines and Healthcare Products Regulatory Agency granted Promising Innovative Medicine designation to Soligenix’s SGX945 (dusquetide) for the treatment of Behçet’s disease.
• The recent designation in the United Kingdom builds on other regulatory recognitions previously granted to dusquetide.

Regulatory recognition from international health authorities can significantly shape the trajectory of emerging therapies worldwide, particularly in rare disease development where clinical pathways are often complex and resource intensive. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases and unmet medical needs, recently received such recognition as its investigational therapy SGX945 was granted Promising Innovative Medicine (“PIM”) designation by the United Kingdom’s (“UK’s”) Medicines and Healthcare products Regulatory Agency (“MHRA”).

Designations granted by leading regulatory agencies play a critical role in advancing drug-development programs. These recognitions often signal that a therapy shows potential to address serious conditions where few treatment options exist. According to the UK MHRA, the PIM designation is awarded to medicines that appear to offer a major advantage over existing treatment options or benefit patients who currently have no adequate therapy available. The designation serves as an early step in the UK’s Early Access to Medicines Scheme, which was created to help patients with life-threatening or seriously debilitating conditions gain access to promising treatments before full marketing authorization.

Programs such as the Early Access to Medicines Scheme reflect a broader global effort among regulators to accelerate development pathways for therapies that address urgent medical needs. Regulatory agencies, including the U.S. Food and Drug Administration (“FDA”) and the European Medicines Agency, have developed similar initiatives designed to encourage innovation while maintaining safety standards. The FDA’s accelerated approval and breakthrough therapy pathways, for example, are intended to speed the development of drugs that treat serious diseases and fill an unmet medical need. These programs recognize that patients with severe or rare conditions often cannot wait for the traditional timelines associated with drug development.

Such designations are particularly important in the rare-disease sector, where patient populations are small and the scientific challenges are often complex. The World Health Organization notes that rare diseases collectively affect an estimated 300 million people worldwide. Because most rare diseases still lack approved treatments, regulatory frameworks that encourage innovation and accelerate access to promising therapies have become essential components of modern drug development.

Soligenix’s recent regulatory milestone reflects this global environment of collaboration between biotechnology innovators and health authorities. Earlier this month, the company announced that  the UK MHRA granted PIM designation to its SGX945 (dusquetide) for the treatment of Behçet’s disease. This designation recognizes the therapy’s potential to address a serious condition with limited treatment options and represents an important step toward possible inclusion in the Early Access to Medicines Scheme.

SGX945 is an injectable formulation of the innate defense regulator, dusquetide, designed to modulate the body’s natural immune response, help to balance inflammation, enhance pathogen clearance and support tissue healing. This approach represents a novel strategy for treating inflammatory and immune-related disorders, particularly those involving chronic or dysregulated innate immune responses. 

The therapy is being developed to treat Behçet’s disease, a rare and incurable inflammatory disorder that causes blood vessel inflammation throughout the body. The condition can produce recurring symptoms including painful oral and genital ulcers, skin lesions and inflammation affecting multiple organ systems. Because Behçet’s disease can significantly impact quality of life and may lead to serious complications, the development of new therapies remains an important focus within rare disease medicine.

Clinical data highlight the potential of SGX945 in addressing these symptoms. In a phase 2a pilot study involving patients with Behçet’s disease, treatment with SGX945 demonstrated improvements in oral ulcer outcomes, with positive responses observed in seven of eight treated patients. The therapy was also reported to be well tolerated in the study, with no treatment-related adverse events observed during the trial period.

The recent designation in the UK builds on other regulatory recognitions previously granted to dusquetide. The therapy has received fast track and orphan drug designations from the FDA for Behçet’s disease, reflecting the therapy’s potential importance in treating a rare condition with limited available treatment options. 

In addition, earlier this year, the European Medicines Agency Committee for Orphan Medicinal Products provided a positive recommendation on the company’s request for orphan drug designation with the next step in the process being ratification of the positive opinion by the European Commission. Such designations can provide incentives that support continued clinical development, including regulatory guidance and potential market exclusivity benefits once a therapy is approved.

Soligenix continues to advance a diversified pipeline built around its specialized biotherapeutics platform. The company’s programs target rare inflammatory conditions, oncology indications such as cutaneous T-cell lymphoma and additional infectious disease applications. By leveraging its scientific platforms and focusing on diseases with limited therapeutic options, the company seeks to develop innovative treatments that address areas of significant unmet medical need.

The PIM designation granted to SGX945 represents another step forward in that strategy. As regulatory agencies around the world work to accelerate the development of therapies for serious and rare conditions, recognitions such as this help signal scientific progress while opening pathways that may ultimately bring new treatment options more quickly to patients who currently have few alternatives.

For more information, visit www.Soligenix.com.

NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

• Safe Pro Group delivers AI, drone-based services, and ballistic protective gear, to customers in the defense, law enforcement, humanitarian, and homeland security industries.
• At the heart of the company’s mission is a computer vision technology used to rapidly detect and identify small explosive objects such as landmines in drone footage, enabling safer and more efficient field operations in both conflict and post-conflict zones.
• The company maintains close communication with government and commercial clients, recently signing and completing key contracts.

Safe Pro Group (NASDAQ: SPAI) is a technology company delivering advanced security and defense solutions to customers in government and industry, such as homeland security, law enforcement, defense, humanitarian, and commercial markets.

The company is addressing the global multi-billion dollar need for scalable defense, demining, and public safety solutions. Safe Pro Group has three business units that each play a distinct role in supporting these efforts and missions across the world.

Safe Pro AI

Safe Pro AI’s AI-powered computer vision technology helps to rapidly analyze drone footage to autonomously identify and detect small explosive objects. The flagship product, SpotlightAI(TM), is capable of detecting and identifying over 150 types of explosive threats such as landmines, cluster munitions, and unexploded ordnance (“UXO”).

The platform is built on more than three years of real-world usage in Ukraine and also includes imagery being gathered from Africa, Asia Pacific and more recently, the Middle East. In total, the platform boasts a dataset of over 2.4 million images and has identified well over 45,600 threats.

Airborne Response

Airborne Response is the company’s Mission Critical Unmanned Solutions subsidiary and provides drone services using U.S. Government-compliant small uncrewed aircraft systems (“sUAS”) (or drones). It serves companies in industries like telecom, utilities, and insurance, and offers a full-range of inspection and monitoring solutions as well as Drone-as-a-First Responder (“DFR”) services for public safety and law enforcement.

Safe-Pro USA

This is the company’s ballistic protection subsidiary that provides American-made ballistic protection systems including body armor, ballistic plates, and complete Explosive Ordnance Disposal (“EOD”) suits, bomb blankets, and demining aprons. All products it makes meet or exceed NATO and U.S. standards, and are designed, engineered, and produced in the USA.

Safe Pro Group recently secured a contract from the U.S. Government to supply AI-powered edge processing systems valued at $1 million. The company executed the delivery of the systems only 15 days after receiving the award. In addition, the company’s subsidiary, Airborne Response, recently received a purchase order from a multinational telecommunications firm, for the use of drones to conduct aerial inspection and asset management services supporting communication infrastructure used by first responders in South Florida, ensuring that it is resilient and reliable.

Safe Pro Group maintains communications with the U.S. Army, recently demonstrating the company’s integrated AI capabilities during the U.S. Army’s Transforming in Contact (“TiC”) 2.0 Autonomous Breach Event at Fort Hood, Texas (https://ibn.fm/9Dxch).

The company’s team is led by the CEO, Dan Erdberg, who has more than 20 years experience as a tech executive under his belt. He’s led multiple Nasdaq listings in the drone, 5G, and satellite communications sectors, and has raised more than $50 million in growth capital.

About Safe Pro Group Inc. (NASDAQ: SPAI)

Safe Pro Group is a mission-driven tech company that offers AI-powered security and defense solutions to a range of clients. The core of the company’s mission revolves around computer vision technology that rapidly identifies and detects small explosive threats in drone imagery, to make field operations safer for ground teams.

For more information, visit the company’s website at www.SafeProGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SPAI are available in the company’s newsroom at  https://ibn.fm/SPAI

• Recent research shows how chemotherapy and immunotherapy can complement each other when used together.
• Within this evolving scientific landscape, LIXTE Biotechnology is pursuing a strategy designed to improve the performance of existing cancer treatments.
• Inhibiting PP2A with LB-100 may increase tumor sensitivity to chemotherapy and radiation while also enhancing immune system activity against cancer cells.

Experts working across oncology are exploring how different treatment approaches can work together to improve outcomes for cancer patients. One area drawing significant attention involves combining immunotherapy with chemotherapy to help the immune system better recognize and attack tumors. LIXTE Biotechnology Holdings (NASDAQ: LIXT) is working within this emerging field through the development of its experimental compound LB-100, which is designed to enhance the effectiveness of existing cancer therapies by targeting biological mechanisms that influence immune recognition and tumor sensitivity to treatment.

Interest in combining therapies stems from the reality that many cancers do not respond adequately to immunotherapy alone. Immune checkpoint inhibitors, which block proteins such as PD-1 or PD-L1 to enable immune cells to attack tumors, have transformed treatment for certain cancers but still leave many patients without durable responses. Researchers therefore continue to investigate methods that can make tumors more visible to the immune system and improve the effectiveness of immune-based therapies.

Recent research shows how chemotherapy and immunotherapy can complement each other when used together. The research explains that chemotherapy can sometimes increase the effectiveness of immunotherapy by altering the tumor microenvironment and increasing the release of tumor antigens. These antigens serve as signals that help the immune system recognize cancer cells as targets. According to Dana-Farber researchers, chemotherapy may also reduce certain immune-suppressive cells within tumors, which can make immune checkpoint inhibitors more effective.

The concept behind this approach is that certain therapies, including chemotherapy, may help convert tumors that are immunologically “cold,” meaning they attract little immune attention, into tumors that are “hot,” meaning they are more visible and vulnerable to immune attack. Scientific reviews explain that treatments capable of inducing tumor antigen release and increasing immune cell infiltration can remodel the tumor microenvironment and improve the effectiveness of immunotherapy. As researchers note, strategies that increase T-cell infiltration and immune activation may transform cold tumors into hot tumors, thereby enhancing response to immune checkpoint inhibitors and other immune-based therapies.

Complementing this perspective is a National Institutes of Health article that examines the broader mechanisms underlying tumor immunogenicity and immune response. The review highlights how tumor immunogenicity, antigen presentation and T-cell activation play key roles in determining whether immunotherapies will be effective. Tumors that lack sufficient immune recognition signals often resist treatment because the immune system does not adequately identify them as threats.

The study further explains that therapies capable of altering the tumor microenvironment or increasing antigen production may enhance the response to checkpoint inhibitors and other immunotherapies. Strategies that increase neo-antigen formation, promote immune cell infiltration, or activate T-cell responses are being actively studied as ways to overcome immunotherapy resistance. These scientific insights have fueled growing interest in drugs that modify tumor biology rather than directly killing cancer cells.

Within this evolving scientific landscape, LIXTE Biotechnology is pursuing a strategy designed to improve the performance of existing cancer treatments. The company is developing LB-100, a small-molecule inhibitor that targets protein phosphatase 2A, commonly referred to as PP2A. This enzyme plays a role in regulating cellular processes such as DNA damage repair, cell cycle progression and immune signaling pathways.

According to the company, inhibiting PP2A with LB-100 may increase tumor sensitivity to chemotherapy and radiation while also enhancing immune system activity against cancer cells. LIXTE’s research suggests that PP2A inhibition can stimulate neo-antigen production and promote T-cell proliferation, potentially improving immune recognition of tumors. This mechanism aligns with broader research, which emphasizes the importance of improving tumor immunogenicity to increase the effectiveness of immunotherapy.

LIXTE describes its approach as one that complements existing cancer treatments rather than replacing them. By targeting cellular pathways that influence how tumors interact with the immune system, LB-100 may help make traditional treatments more effective. The company is therefore investigating the compound in combination with chemotherapy, radiation therapy and immune checkpoint inhibitors in various research settings.

Clinical studies have been exploring the potential applications of LB-100 across multiple tumor types. Information available through clinical trial registries indicates that LB-100 has been evaluated in early-stage clinical trials involving patients with advanced solid tumors to assess safety and therapeutic potential. These studies aim to determine whether the compound can enhance the effectiveness of existing therapies in difficult-to-treat cancers.

Beyond its clinical trials, LIXTE continues to explore how PP2A inhibition may influence immune signaling and tumor response in different cancer types. The company believes the mechanism behind LB-100 may be applicable across several solid tumors where resistance to immunotherapy remains a major challenge. If therapies such as LB-100 can successfully improve immune recognition of tumors, they may help expand the number of patients who benefit from modern immunotherapies.

The broader oncology community continues to investigate new ways to overcome the limitations of current treatments. Combining chemotherapy with immunotherapy, along with developing agents that modify tumor immunogenicity, represents a promising direction in cancer research. These strategies aim to transform tumors that evade immune detection into ones that can be effectively targeted by the immune system.

As these approaches evolve, companies working to enhance existing therapies may play an increasingly important role in oncology innovation. Through the development of LB-100 and its research into PP2A inhibition, LIXTE Biotechnology Holdings is participating in the scientific effort to improve how the immune system recognizes and attacks cancer. By focusing on mechanisms that influence tumor immunogenicity and treatment sensitivity, the company aims to contribute to the next generation of combination cancer therapies.

For more information, visit the company website at https://lixte.com.

NOTE TO INVESTORS: The latest news and updates relating to LIXT are available in the company’s newsroom at ibn.fm/LIXT

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

• LaFleur Minerals is a Canada-headquartered near-term gold producer, leveraging its mine and mill assets in the prolific Abitibi Gold Belt, Quebec, to restart gold production in Q22026
• LaFleur’s top management will conduct a live webinar on Tuesday, March 24, to discuss the company’s recent developments, the pending resumption of gold production within the next few months, and LaFleur’s long-term vision of consolidation and scalability
• The company’s Swanson Gold Project and Beacon Gold Mill assets have the potential to produce significant economic returns under a capital-efficient strategy, per the recently released positive PEA
• In addition, LaFleur announced important changes to its Board of Directors, adding experienced senior mining executives to direct the next stages of LaFleur’s growth

Near-term gold producer LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) has announced changes to its Board of Directors, adding the experienced insights of top management to the group as the company prepares for a live corporate webinar to discuss company developments and the pending restart of its wholly-owned gold mill in Canada’s largest and most prolific gold producing region.

LaFleur’s senior management team will lead the live webinar, including a follow-up question-and-answer session with investors, on March 24 at 9 a.m. PST / Noon EST. It can be accessed via Zoom at https://ibn.fm/hiCgy.

LaFleur has named CEO Paul Ténière and Nicola Mining CEO & President Peter Espig to the Board of Directors, as well as senior mining executive Jeff Swinoga, succeeding Preet Gill and Harveer Sidhu. Swinoga has held senior executive and financial leadership roles with Barrick Gold, Torex Gold Resources, Hudbay Minerals, North American Palladium and Golden Star Resources, according to the March 16 news release. Espig, an advisor to LaFleur, has led Nicola from being a company under creditor protection to becoming a producing mining enterprise with increased market capitalization (https://ibn.fm/8k6sV).

LaFleur has established a significant asset base in the prolific Abitibi Greenstone Belt of Eastern Canada, including the recently refurbished Beacon Gold Mill that has now undergone ~30% of recommissioning work for gold production restart, and the nearby district-scale Swanson Gold Deposit and its recently increased 2026 Mineral Resource Estimate. The company benefits from infrastructure and the Project’s proximity to existing labor and equipment suppliers in the nearby Val d’Or, Quebec mining camp, along with ability to establish direct rail line access from one site to the other enhancing the development potential of its mine-to-mill model.

The company recently reported the results of a positive Preliminary Economic Assessment (“PEA”) that will help the company to develop its roadmap to production profitability, and the results of the PEA will feature as a key element of the webinar presentation on March 24.

The webinar presentation will include an update on ongoing technical work and planned next steps for the company as it aims for restart of gold production at LaFleur’s Abitibi Beacon Gold Mill during the second quarter, a mill with ~$70 million replacement value that was last in operation in 2023. Management will also discuss the company’s long-term vision. The company has benefited from savvy strategic benchmarks positioning it as a junior gold developer with both a clear path to production and potential upside through resource expansion.

LaFleur’s news release also details efforts to increase the company’s visibility with new marketing service contracts providing exposure from Native Ads Inc., InvestorsHub and Mayfair Media Operations Pty Ltd (trading as mining.com.au).

The company’s gold project encompasses approximately 19,214 hectares (47,479 acres) and includes prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. LaFleur’s mission is to develop mining projects with significant potential to deliver long-term value, with low-cost and quick pivot to revenue generation, anticipating that the Swanson and Beacon assets are positioned to fill that need.

For more information, visit the company’s website at LaFleurMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to LFLRF are available in the company’s newsroom at https://ibn.fm/LFLRF

Qualified Person Statement:

All scientific and technical information contained in this article has been reviewed and approved by Louis Martin, P.Geo. (OGQ), Exploration Manager and Technical Advisor of the company and considered a Qualified Person for the purposes of NI 43-101.

• The company aims to deliver a 100-megawatt fusion reactor in 2026, with an earlier 5-MW pre-production system currently in development.
• Initial deployments are expected to focus on behind-the-meter power generation for data centers and industrial facilities.
• Management intends to sell electricity under long-term contracts priced around $0.0625 per kilowatt-hour, competitive with some renewable power sources.
• The company’s plan targets 1 gigawatt of delivered capacity by 2028, followed by rapid expansion if early deployments prove successful.
• Management is preparing a Form 10 registration and potential uplisting, initially to the OTCQB and eventually to a major exchange.

Fusion energy has long been discussed as a potential source of reliable, carbon-free electricity. For decades, however, the technology has remained largely confined to research laboratories and government programs. Now a growing number of private companies are attempting to shorten that timeline. Among them is Renewal Fuels (OTC: RNWF) (d/b/a American Fusion(TM)), an advanced energy platform company focused on the development and commercialization of fusion energy technologies through its subsidiary Kepler Fusion Technologies.

During a recent interview on The Stock2Me Podcast, Kepler’s chief executive Brent Nelson outlined how the company intends to move from development to commercial deployment of its Texatron(TM) fusion system, providing insight into a strategy aimed at bringing fusion power into industrial and infrastructure markets (https://ibn.fm/M6M8r).

Nelson said the company is pursuing what many observers consider an aggressive timeline. “The idea here is that we’re going to be putting electrons either behind the meter or in front of the meter by the end of this year,” he said during the interview.

According to Nelson, the company is currently developing nine different Texatron(TM) models and is now constructing two of their reactor designs: a 5-megawatt system to showcase the technology and a 100-megawatt unit to test commercially. The 100-MW design forms the basis of the company’s commercialization plan. The modular approach allows the firm to build generation capacity in standardized units that can be scaled over time.

In practical terms, Nelson explained, ten 100-MW reactors would equal one gigawatt of generation capacity, providing a framework that investors and infrastructure planners can easily model.

Rather than initially connecting reactors to large power grids, the company plans to deploy units behind the meter, meaning directly at the customer’s facility. That strategy reflects the regulatory complexity associated with connecting new power plants to public electricity networks. “Going behind the meter, it’s really a piece of cake, especially here in Texas,” Nelson said.

Potential customers include data centers, industrial parks and other large electricity consumers. Such facilities often require reliable, round-the-clock power and may benefit from on-site generation.

The company expects grid-connected deployments, sometimes described as “in front of the meter,” to take longer because they require interconnection approvals and regulatory review.

Kepler’s commercial model is structured around power-as-a-service contracts, a structure increasingly common in energy infrastructure projects. Under this approach, the company would build and operate fusion reactors while customers purchase electricity under long-term agreements.

Nelson said pricing in Texas could be around 6.25 cents per kilowatt-hour, which he indicated would allow a 100-MW reactor to generate roughly $54 million in annual revenue if operating at expected output levels. He suggested operating margins could exceed 80% once units are running, though the economics will ultimately depend on construction costs, utilization and operational performance.

If the initial units are deployed successfully, the company plans to expand production rapidly. Nelson said the firm’s internal projections target 1 gigawatt of delivered power capacity by 2028, followed by accelerated expansion in later years.

The scalability of the design is central to that plan. Smaller reactor modules, he said, could be manufactured and transported relatively easily. “A 10-megawatt reactor can fit in the back of a pickup truck,” Nelson said, emphasizing the compact nature of the proposed systems. Such modular designs could allow installations to plug into existing energy infrastructure similar to solar or wind generation sites.

Alongside hardware development, the company is building an intellectual-property portfolio around its Texatron technology. Nelson said the firm is pursuing priority patent filings and a trade-secret program covering key aspects of the reactor design and operating systems.

Patent applications are currently moving through the standard examination process, which can take several years. However, priority filings may be reviewed sooner. Management expects the intellectual-property portfolio to expand significantly as the technology matures. “We’re looking at, probably, at least 260 to 300 patents by the end of this year,” Nelson said.

Demand for electricity in the United States is projected to rise as data centers, electrification and artificial-intelligence infrastructure expand power consumption. Nelson suggested overall U.S. electricity demand could grow roughly 30% over the next several years, creating opportunities for new generation technologies.

The company is also exploring potential partnerships with government agencies and defense organizations. Nelson mentioned discussions with entities including NASA and the Department of War regarding possible future applications. Such engagements typically involve competitive proposal processes and can take years to result in contracts.

From a financial perspective, the company is preparing for a transition to more formal reporting status. Last week, management filed a Form 10 registration statement with the U.S. Securities and Exchange Commission, which would move the company toward full SEC reporting. Nelson said the company also plans to raise approximately $50 million in capital as part of its early commercialization phase.

An uplisting to the OTCQB market is expected to be the first step, followed by a potential move to a larger exchange such as NASDAQ or the planned Texas Stock Exchange.

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to RNWF are available in the company’s newsroom at https://ibn.fm/RNWF